Abstract
This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009).The literature was reviewed based on PubMed and MEDLINE database searches (from January 2009 up to September 2015), including papers in press; for each section/subsection, key title words were used and possibly combined with other more general key-words (such as radiotherapy, dose-volume effects, NTCP, DVH, and predictive model). Publications generally dealing with toxicity without any association with dose-volume effects or correlations with clinical risk factors were disregarded, being outside the aim of the review.A focus was on external beam radiotherapy, including post-prostatectomy, with conventional fractionation or moderate hypofractionation (
| Original language | English |
|---|---|
| Pages (from-to) | 521-532 |
| Number of pages | 12 |
| Journal | Physica Medica |
| Volume | 32 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 1 2016 |
Fingerprint
Keywords
- Acute and late toxicity
- Dose-volume models
- Prostate cancer
- Radiotherapy
ASJC Scopus subject areas
- Biophysics
- Radiology Nuclear Medicine and imaging
- Physics and Astronomy(all)
Cite this
Predicting toxicity in radiotherapy for prostate cancer. / Landoni, Valeria; Fiorino, Claudio; Cozzarini, Cesare; Sanguineti, Giuseppe; Valdagni, Riccardo; Rancati, Tiziana.
In: Physica Medica, Vol. 32, No. 3, 01.03.2016, p. 521-532.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Predicting toxicity in radiotherapy for prostate cancer
AU - Landoni, Valeria
AU - Fiorino, Claudio
AU - Cozzarini, Cesare
AU - Sanguineti, Giuseppe
AU - Valdagni, Riccardo
AU - Rancati, Tiziana
PY - 2016/3/1
Y1 - 2016/3/1
N2 - This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009).The literature was reviewed based on PubMed and MEDLINE database searches (from January 2009 up to September 2015), including papers in press; for each section/subsection, key title words were used and possibly combined with other more general key-words (such as radiotherapy, dose-volume effects, NTCP, DVH, and predictive model). Publications generally dealing with toxicity without any association with dose-volume effects or correlations with clinical risk factors were disregarded, being outside the aim of the review.A focus was on external beam radiotherapy, including post-prostatectomy, with conventional fractionation or moderate hypofractionation (
AB - This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009).The literature was reviewed based on PubMed and MEDLINE database searches (from January 2009 up to September 2015), including papers in press; for each section/subsection, key title words were used and possibly combined with other more general key-words (such as radiotherapy, dose-volume effects, NTCP, DVH, and predictive model). Publications generally dealing with toxicity without any association with dose-volume effects or correlations with clinical risk factors were disregarded, being outside the aim of the review.A focus was on external beam radiotherapy, including post-prostatectomy, with conventional fractionation or moderate hypofractionation (
KW - Acute and late toxicity
KW - Dose-volume models
KW - Prostate cancer
KW - Radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=84963612009&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84963612009&partnerID=8YFLogxK
U2 - 10.1016/j.ejmp.2016.03.003
DO - 10.1016/j.ejmp.2016.03.003
M3 - Article
VL - 32
SP - 521
EP - 532
JO - Physica Medica
JF - Physica Medica
SN - 1120-1797
IS - 3
ER -